These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2589823)

  • 1. Nuclear DNA content and nuclear atypia. Relation to survival in patients with breast adenocarcinoma and serious ovarian tumors.
    Erhardt K; Silfverswärd C; Auer G
    Anticancer Res; 1989; 9(5):1325-30. PubMed ID: 2589823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.
    Auer G; Eriksson E; Azavedo E; Caspersson T; Wallgren A
    Cancer Res; 1984 Jan; 44(1):394-6. PubMed ID: 6690053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of nuclear DNA content in serous ovarian tumors.
    Erhardt K; Auer G; Björkholm E; Forsslund G; Moberger B; Sifverswärd C; Wicksell G; Zetterberg A
    Cancer Res; 1984 May; 44(5):2198-202. PubMed ID: 6713406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nuclear image cytometry, histopathological grading and DNA cytometry to make breast cancer prognosis more objective.
    Theissig F; Dimmer V; Haroske G; Kunze KD; Meyer W
    Anal Cell Pathol; 1991 Nov; 3(6):351-60. PubMed ID: 1751402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cell nucleus analyses on the heterogenicity, proliferation and metastasis of malignant tumors].
    Kunze KD; Haroske G; Dimmer V; Meyer W; Theissig F
    Acta Histochem Suppl; 1990; 39():147-54. PubMed ID: 1964231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor.
    Kieback DG; McCamant SK; Press MF; Atkinson EN; Gallager HS; Edwards CL; Hajek RA; Jones LA
    Cancer Res; 1993 Nov; 53(21):5188-92. PubMed ID: 8221656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group.
    Vacher-Lavenu MC; Le Tourneau A; Duvillard P; Godefroy N; Pinel MC
    Bull Cancer; 1993 Feb; 80(2):135-41. PubMed ID: 8173164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of DNA content and nuclear morphology in borderline ovarian tumors.
    Drescher CW; Flint A; Hopkins MP; Roberts JA
    Gynecol Oncol; 1993 Feb; 48(2):242-6. PubMed ID: 8428698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression.
    Veltri RW; Partin AW; Epstein JE; Marley GM; Miller CM; Singer DS; Patton KP; Criley SR; Coffey DS
    J Cell Biochem Suppl; 1994; 19():249-58. PubMed ID: 7529856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized image analysis and flow cytometric evaluation of ovarian borderline tumors: a study of 24 cases.
    Esposito MJ; Fuchs A
    Cytometry; 1994 Dec; 18(4):218-22. PubMed ID: 7895528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.
    Leal C; Henrique R; Monteiro P; Lopes C; Bento MJ; De Sousa CP; Lopes P; Olson S; Silva MD; Page DL
    Hum Pathol; 2001 May; 32(5):487-93. PubMed ID: 11381366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between image cytometric DNA index, proliferation fraction and multiploidy and conventional nuclear grade in breast carcinoma.
    Smith FB; Zappi ME
    Mod Pathol; 1993 Sep; 6(5):606-11. PubMed ID: 7504261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of the cytological grading, the nuclear area, the DNA index and the DNA histogram type in the setting up of a score for ductal breast carcinoma.
    Budel V; Merle S; Gasperin P; Collet JF; De Maublanc MA; Kiss R
    Anticancer Res; 1994; 14(6B):2845-51. PubMed ID: 7532932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer metastatic phenotype as predicted by histologic tumor markers.
    Heimann R; Ferguson D; Recant WM; Hellman S
    Cancer J Sci Am; 1997; 3(4):224-9. PubMed ID: 9263628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of mammary adenocarcinomas as reflected by nuclear DNA content.
    Auer GU; Fallenius AG; Erhardt KY; Sundelin BS
    Cytometry; 1984 Jul; 5(4):420-5. PubMed ID: 6468180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ.
    Aulmann S; Elsawaf Z; Penzel R; Schirmacher P; Sinn HP
    Am J Surg Pathol; 2009 Nov; 33(11):1646-53. PubMed ID: 19675453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and bcl-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median follow-up of 60 months.
    Geisler JP; Geisler HE; Miller GA; Wiemann MC; Zhou Z; Crabtree W
    Gynecol Oncol; 2000 May; 77(2):278-82. PubMed ID: 10785478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors.
    Tajima Y; Nakanishi Y; Ochiai A; Tachimori Y; Kato H; Watanabe H; Yamaguchi H; Yoshimura K; Kusano M; Shimoda T
    Cancer; 2000 Mar; 88(6):1285-93. PubMed ID: 10717608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.